Hajar Alqahtani

发表

Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19

A. Alothman, E. Mahmoud, S. Aljohani, 2021, BMJ Open.

IgA Nephropathy Flare-Up Mimicking Staphylococcus Post-Infection Glomerulonephritis in Patient with Staphylococcus Aureus Infection Treated with Cefazolin: A Case Report and Brief Review of the Literature

F. Alqahtani, F. Aleanizy, Hajar Alqahtani, 2019, The American journal of case reports.

Outcomes associated with tocilizumab with or without corticosteroid versus dexamethasone for treatment of patients with severe to critical COVID-19 pneumonia

F. Alqahtani, F. Aleanizy, E. Mahmoud, 2021, Journal of Infection and Public Health.

Evaluating the effect of antibiotics sub-inhibitory dose on Pseudomonas aeruginosa quorum sensing dependent virulence and its phenotypes

F. Alqahtani, F. Aleanizy, Thamer A. Almangour, 2020, Saudi journal of biological sciences.

Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial

Y. Arabi, A. Bouchama, Faisal Alharbi, 2021, Infectious Diseases and Therapy.

Infections and patterns of antibiotic utilization in support and comfort care patients: A tertiary care center experience.

E. Mahmoud, Hajar Alqahtani, H. Alhatmi, 2021, Journal of infection and public health.

Evaluation of the Clinical Outcome and Cost Analysis of Antibiotics in the Treatment of Acute Respiratory Tract Infections in the Emergency Department in Saudi Arabia

F. Alqahtani, F. Aleanizy, Menyfah Q. Alanazi, 2022, Antibiotics.

Antibacterial Activity of Chitosan Nanoparticles Against Pathogenic N. gonorrhoea

F. Alqahtani, F. Aleanizy, I. Alsarra, 2020, International journal of nanomedicine.

Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial

K. Alabdulkareem, F. Alrabiah, E. Mahmoud, 2022, Clinical Microbiology and Infection.

Clinical characteristics and risk factors of patients with severe COVID-19 in Riyadh, Saudi Arabia: A retrospective study

Bahauddeen M. Alrfaei, G. Shamlan, N. Al-Maflehi, 2021, Journal of Infection and Public Health.

Treatment of Recurrent Clostridium difficile Infection in an Immunocompromised Patient with Severe Neutropenia Not Responding to Standard Therapy

Hajar Alqahtani, Saeed A. Baloch, Deanne E Tabb, 2020, Case reports in infectious diseases.

Evaluation of ceftazidime/avibactam for treatment of carbapenemase-producing carbapenem-resistant Enterobacterales with OXA-48 and/or NDM genes with or without combination therapy

F. Farahat, E. Mahmoud, M. Bosaeed, 2022, JAC-antimicrobial resistance.

Influence of the minimum inhibitory concentration of daptomycin on the outcomes of Staphylococcus aureus bacteremia.

F. Alqahtani, F. Aleanizy, Hajar Alqahtani, 2020, Journal of global antimicrobial resistance.